[FOLD] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[FOLD] Amicus Therapeutics, Inc.
Announcement Date
08-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 18.33%
YoY- 30.45%
Quarter Report
FOLD's Result
FOLD's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 126,669 94,503 80,731 77,413 62,353 44,130 21,309 34.55%
PBT 108 -40,517 -61,246 -46,700 -48,789 -83,834 -61,494 -
Tax 15,805 2,715 911 4,525 3,703 717 339 89.60%
NP -15,697 -43,232 -62,157 -51,225 -52,492 -84,551 -61,833 -20.41%
Tax Rate -14,634.26% - - - - - - -
Total Cost 142,366 137,735 142,888 128,638 114,845 128,681 83,142 9.36%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -12.39 -45.75 -76.99 -66.17 -84.19 -191.60 -290.17 -40.85%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.05 -0.15 -0.21 -0.19 -0.20 -0.36 -0.33 -26.96%
EPS Diluted -0.05 -0.15 -0.21 -0.19 -0.20 -0.36 -0.33 -26.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.